Electrochemical  ||| S:0 E:16 ||| JJ
deposition  ||| S:16 E:27 ||| NN
of  ||| S:27 E:30 ||| IN
the  ||| S:30 E:34 ||| DT
new  ||| S:34 E:38 ||| JJ
manganese ||| S:38 E:47 ||| NNS
( ||| S:47 E:48 ||| -LRB-
II ||| S:48 E:50 ||| NNP
)  ||| S:50 E:52 ||| -RRB-
Schiff-base  ||| S:52 E:64 ||| JJ
complex  ||| S:64 E:72 ||| NN
on  ||| S:72 E:75 ||| IN
a  ||| S:75 E:77 ||| DT
gold  ||| S:77 E:82 ||| NN
template  ||| S:82 E:91 ||| NNS
and  ||| S:91 E:95 ||| CC
its  ||| S:95 E:99 ||| PRP$
application  ||| S:99 E:111 ||| NN
for  ||| S:111 E:115 ||| IN
dopamine  ||| S:115 E:124 ||| JJ
sensing  ||| S:124 E:132 ||| NN
in  ||| S:132 E:135 ||| IN
the  ||| S:135 E:139 ||| DT
presence  ||| S:139 E:148 ||| NN
of  ||| S:148 E:151 ||| IN
interfering  ||| S:151 E:163 ||| FW
biogenic  ||| S:163 E:172 ||| FW
compounds  ||| S:172 E:182 ||| FW
Facile  ||| S:182 E:189 ||| NNP
and  ||| S:189 E:193 ||| CC
efficient  ||| S:193 E:203 ||| JJ
template  ||| S:203 E:212 ||| JJ
synthesis  ||| S:212 E:222 ||| NN
of  ||| S:222 E:225 ||| IN
new  ||| S:225 E:229 ||| JJ
manganese ||| S:229 E:238 ||| NNS
( ||| S:238 E:239 ||| -LRB-
II ||| S:239 E:241 ||| NNP
)  ||| S:241 E:243 ||| -RRB-
complex  ||| S:243 E:251 ||| NN
[ ||| S:251 E:252 ||| -LRB-
Mn2 ||| S:252 E:255 ||| NNP
( ||| S:255 E:256 ||| -LRB-
H2L ||| S:256 E:259 ||| NNP
) ||| S:259 E:260 ||| -RRB-
2 ||| S:260 E:261 ||| CD
] ||| S:261 E:262 ||| -RRB-
( ||| S:262 E:263 ||| -LRB-
ClO4 ||| S:263 E:267 ||| NNP
) ||| S:267 E:268 ||| -RRB-
2  ||| S:268 E:270 ||| CD
( ||| S:270 E:271 ||| -LRB-
1 ||| S:271 E:272 ||| LS
)  ||| S:272 E:274 ||| -RRB-
and  ||| S:274 E:278 ||| CC
its  ||| S:278 E:282 ||| PRP$
crystal  ||| S:282 E:290 ||| NN
structure  ||| S:290 E:300 ||| NN
are  ||| S:300 E:304 ||| VBP
reported ||| S:304 E:312 ||| VBN
.  ||| S:312 E:314 ||| .
Self-assembly  ||| S:314 E:328 ||| NNP
leads  ||| S:328 E:334 ||| VBZ
to  ||| S:334 E:337 ||| TO
the  ||| S:337 E:341 ||| DT
formation  ||| S:341 E:351 ||| NN
of  ||| S:351 E:354 ||| IN
dinuclear ||| S:354 E:363 ||| NN
,  ||| S:363 E:365 ||| ,
phenoxo-bridged  ||| S:365 E:381 ||| NNP
closed  ||| S:381 E:388 ||| VBD
species  ||| S:388 E:396 ||| VBN
via  ||| S:396 E:400 ||| IN
exploitation  ||| S:400 E:413 ||| NN
of  ||| S:413 E:416 ||| IN
both  ||| S:416 E:421 ||| DT
binding  ||| S:421 E:429 ||| JJ
subunits  ||| S:429 E:438 ||| NN
of  ||| S:438 E:441 ||| IN
the  ||| S:441 E:445 ||| DT
in  ||| S:445 E:448 ||| IN
situ  ||| S:448 E:453 ||| NN
formed  ||| S:453 E:460 ||| VBD
new  ||| S:460 E:464 ||| JJ
Schiff-base  ||| S:464 E:476 ||| JJ
ligand ||| S:476 E:482 ||| NN
.  ||| S:482 E:484 ||| .
Gold  ||| S:484 E:489 ||| NNP
electrode  ||| S:489 E:499 ||| VBD
modified  ||| S:499 E:508 ||| VBN
with  ||| S:508 E:513 ||| IN
self-assembled  ||| S:513 E:528 ||| JJ
monolayers  ||| S:528 E:539 ||| NNS
( ||| S:539 E:540 ||| -LRB-
SAMs ||| S:540 E:544 ||| NNP
)  ||| S:544 E:546 ||| -RRB-
composed  ||| S:546 E:555 ||| VBN
of  ||| S:555 E:558 ||| IN
synthesized  ||| S:558 E:570 ||| JJ
complex  ||| S:570 E:578 ||| JJ
1  ||| S:578 E:580 ||| CD
was  ||| S:580 E:584 ||| VBD
applied  ||| S:584 E:592 ||| VBN
as  ||| S:592 E:595 ||| IN
a  ||| S:595 E:597 ||| DT
voltammetric  ||| S:597 E:610 ||| JJ
sensor  ||| S:610 E:617 ||| NN
for  ||| S:617 E:621 ||| IN
quantitative  ||| S:621 E:634 ||| JJ
determination  ||| S:634 E:648 ||| NN
of  ||| S:648 E:651 ||| IN
dopamine  ||| S:651 E:660 ||| NNS
( ||| S:660 E:661 ||| -LRB-
DA ||| S:661 E:663 ||| NNP
)  ||| S:663 E:665 ||| -RRB-
in  ||| S:665 E:668 ||| IN
the  ||| S:668 E:672 ||| DT
presence  ||| S:672 E:681 ||| NN
of  ||| S:681 E:684 ||| IN
ascorbic  ||| S:684 E:693 ||| NNS
( ||| S:693 E:694 ||| -LRB-
AA ||| S:694 E:696 ||| NN
)  ||| S:696 E:698 ||| -RRB-
and  ||| S:698 E:702 ||| CC
uric  ||| S:702 E:707 ||| JJ
acids  ||| S:707 E:713 ||| NNS
( ||| S:713 E:714 ||| -LRB-
UA ||| S:714 E:716 ||| NNP
) ||| S:716 E:717 ||| -RRB-
.  ||| S:717 E:719 ||| .
The  ||| S:719 E:723 ||| DT
linear  ||| S:723 E:730 ||| JJ
relationship  ||| S:730 E:743 ||| NN
between  ||| S:743 E:751 ||| IN
the  ||| S:751 E:755 ||| DT
current  ||| S:755 E:763 ||| JJ
response  ||| S:763 E:772 ||| NN
of  ||| S:772 E:775 ||| IN
dopamine  ||| S:775 E:784 ||| NN
at  ||| S:784 E:787 ||| IN
the  ||| S:787 E:791 ||| DT
potential  ||| S:791 E:801 ||| NN
of  ||| S:801 E:804 ||| IN
peak  ||| S:804 E:809 ||| JJ
maximum  ||| S:809 E:817 ||| NN
and  ||| S:817 E:821 ||| CC
the  ||| S:821 E:825 ||| DT
concentration  ||| S:825 E:839 ||| NN
was  ||| S:839 E:843 ||| VBD
found  ||| S:843 E:849 ||| VBN
over  ||| S:849 E:854 ||| IN
a  ||| S:854 E:856 ||| DT
wide  ||| S:856 E:861 ||| JJ
analyte  ||| S:861 E:869 ||| JJ
concentration  ||| S:869 E:883 ||| NN
range  ||| S:883 E:889 ||| NN
( ||| S:889 E:890 ||| -LRB-
R ||| S:890 E:891 ||| NNP
( ||| S:891 E:892 ||| -LRB-
2 ||| S:892 E:893 ||| LS
) ||| S:893 E:894 ||| -RRB-
≥0.993 ||| S:894 E:900 ||| NNP
,  ||| S:900 E:902 ||| ,
1×10 ||| S:902 E:906 ||| NNP
( ||| S:906 E:907 ||| -LRB-
-10 ||| S:907 E:910 ||| NNP
) ||| S:910 E:911 ||| -RRB-
-8.5×10 ||| S:911 E:918 ||| NNP
( ||| S:918 E:919 ||| -LRB-
-4 ||| S:919 E:921 ||| NNP
) ||| S:921 E:922 ||| -RRB-
M ||| S:922 E:923 ||| NNP
)  ||| S:923 E:925 ||| -RRB-
with  ||| S:925 E:930 ||| IN
a  ||| S:930 E:932 ||| DT
very  ||| S:932 E:937 ||| RB
good  ||| S:937 E:942 ||| JJ
sensitivity  ||| S:942 E:954 ||| NN
( ||| S:954 E:955 ||| -LRB-
4.11Acm ||| S:955 E:962 ||| NNP
( ||| S:962 E:963 ||| -LRB-
-2 ||| S:963 E:965 ||| NNP
) ||| S:965 E:966 ||| -RRB-
M ||| S:966 E:967 ||| NNP
( ||| S:967 E:968 ||| -LRB-
-1 ||| S:968 E:970 ||| NNP
)  ||| S:970 E:972 ||| -RRB-
at  ||| S:972 E:975 ||| IN
dE ||| S:975 E:977 ||| NNP
/ ||| S:977 E:978 ||| NNP
dt=0.1Vs ||| S:978 E:986 ||| NNP
( ||| S:986 E:987 ||| -LRB-
-1 ||| S:987 E:989 ||| NNP
) ||| S:989 E:990 ||| -RRB-
) ||| S:990 E:991 ||| -RRB-
,  ||| S:991 E:993 ||| ,
high  ||| S:993 E:998 ||| JJ
detection  ||| S:998 E:1008 ||| JJ
limit  ||| S:1008 E:1014 ||| NN
( ||| S:1014 E:1015 ||| -LRB-
6.8×10 ||| S:1015 E:1021 ||| NNP
( ||| S:1021 E:1022 ||| -LRB-
-9 ||| S:1022 E:1024 ||| NNP
) ||| S:1024 E:1025 ||| -RRB-
M ||| S:1025 E:1026 ||| NNP
)  ||| S:1026 E:1028 ||| -RRB-
and  ||| S:1028 E:1032 ||| CC
excellent  ||| S:1032 E:1042 ||| JJ
reproducibility ||| S:1042 E:1057 ||| NN
.  ||| S:1057 E:1059 ||| .
It  ||| S:1059 E:1062 ||| PRP
has  ||| S:1062 E:1066 ||| VBZ
been  ||| S:1066 E:1071 ||| VBN
proven  ||| S:1071 E:1078 ||| VBN
that  ||| S:1078 E:1083 ||| IN
current  ||| S:1083 E:1091 ||| JJ
peaks  ||| S:1091 E:1097 ||| NNS
of  ||| S:1097 E:1100 ||| IN
dopamine ||| S:1100 E:1108 ||| NN
,  ||| S:1108 E:1110 ||| ,
ascorbic  ||| S:1110 E:1119 ||| NN
and  ||| S:1119 E:1123 ||| CC
uric  ||| S:1123 E:1128 ||| JJ
acids  ||| S:1128 E:1134 ||| NNS
were  ||| S:1134 E:1139 ||| VBD
clearly  ||| S:1139 E:1147 ||| RB
separated  ||| S:1147 E:1157 ||| VBN
from  ||| S:1157 E:1162 ||| IN
each  ||| S:1162 E:1167 ||| DT
other ||| S:1167 E:1172 ||| JJ
,  ||| S:1172 E:1174 ||| ,
thus  ||| S:1174 E:1179 ||| RB
enabling  ||| S:1179 E:1188 ||| VBG
selective  ||| S:1188 E:1198 ||| JJ
detection  ||| S:1198 E:1208 ||| NN
of  ||| S:1208 E:1211 ||| IN
these  ||| S:1211 E:1217 ||| DT
compounds  ||| S:1217 E:1227 ||| JJ
coexisting  ||| S:1227 E:1238 ||| NN
in  ||| S:1238 E:1241 ||| IN
a  ||| S:1241 E:1243 ||| DT
mixture ||| S:1243 E:1250 ||| NN
.  ||| S:1250 E:1252 ||| .
